The Lancet
订阅
1. [Correspondence] The need for point-of-care tests for mpox Ranu S Dhillon, Abraar Karan, Devabhaktuni Srikrishna, Jean-Vivien Mombouli
2. [Comment] Advancing the economics of health for all Mariana Mazzucato, Tedros Adhanom Ghebreyesus
3. [Comment] Addressing global gun violence: a Lancet Commission on Global Gun Violence and Health Adnan A Hyder, Lorena Barberia, Lancet Commission on Global Gun Violence and Health
4. [Correspondence] A crisis of safety: female health-care workers in India need reforms Gururaj Arakeri, Vishal Rao, Shankargouda Patil
5. [Correspondence] Mpox in eastern Democratic Republic of the Congo: challenges and prospects for vaccination Harry César Kayembe Ntumba, Bien-Aimé Makasa Mandja
6. [Department of Error] Department of Error
7. [Comment] Optical coherence tomography imaging for complex percutaneous coronary intervention Mamas A Mamas, Gary S Mintz
8. [Comment] How feasible is a cage-free solution for de novo coronary artery disease? Margaret B McEntegart, Ajay J Kirtane
9. [Articles] Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea Sung-Jin Hong, Seung-Jun Lee, Sang-Hyup Lee, Jong-Young Lee, Deok-Kyu Cho, Jin Won Kim, Sang Min Kim, Seung-Ho Hur, Jung Ho Heo, Ji-Yong Jang, Jin Sin Koh, Hoyoun Won, Jun-Won Lee, Soon Jun Hong, Dong-Kie Kim, Jeong Cheon Choe, Jin Bae Lee, Soo-Joong Kim, Tae-Hyun Yang, Jung-Hee Lee, Young Joon Hong, Jong-Hwa Ahn, Yong-Joon Lee, Chul-Min Ahn, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Byeong-Keuk Kim, OCCUPI investigators
10. [Articles] Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial Chao Gao, Xingqiang He, Fan Ouyang, Zhihui Zhang, Guidong Shen, Mingxing Wu, Ping Yang, Likun Ma, Feng Yang, Zheng Ji, Hua Wang, Yanqing Wu, Zhenfei Fang, Hong Jiang, Shangyu Wen, Yi Liu, Fei Li, Jingyu Zhou, Bin Zhu, Yunpeng Liu, Ruining Zhang, Tingting Zhang, Ping Wang, Jianzheng Liu, Zhiwei Jiang, Jielai Xia, Robert-Jan van Geuns, Davide Capodanno, Scot Garg, Yoshinobu Onuma, Duolao Wang, Patrick W Serruys, Ling Tao, REC-CAGEFREE I Investigators
11. [Articles] Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up Holger Thiele, Jacob E Møller, Jose P S Henriques, Margriet Bogerd, Melchior Seyfarth, Daniel Burkhoff, Petr Ostadal, Richard Rokyta, Jan Belohlavek, Steffen Massberg, Marcus Flather, Matthias Hochadel, Steffen Schneider, Steffen Desch, Anne Freund, Hans Eiskjær, Norman Mangner, Janine Pöss, Amin Polzin, P Christian Schulze, Carsten Skurk, Uwe Zeymer, Christian Hassager, MCS Collaborator Scientific Group
12. [Comment] Optimal patient and mechanical circulatory support device selection in acute myocardial infarction cardiogenic shock Jacob C Jentzer, Benjamin Hibbert
13. [Articles] Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis Pardeep S Jhund, Atefeh Talebi, Alasdair D Henderson, Brian L Claggett, Muthiah Vaduganathan, Akshay S Desai, Carolyn S P Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Scott D Solomon, John J V McMurray
14. [Comment] Mineralocorticoid receptor antagonists for every patient with heart failure Frans H Rutten, Amy Groenewegen
15. [Correspondence] Mpox threat: Pakistan must act now Saad Javed, Nimirta Sahitia, Eesha Yaqoob
16. [Correspondence] Enhancing mpox response in Africa with implementation science Abdu A Adamu, Joseph Okeibunor, Reena H Doshi, Charles S Wiysonge
17. [Seminar] Primary biliary cholangitis Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, John M Vierling
18. [Comment] Primary health-care practices for deaf children should include early incorporation of a signed language Wyatte C Hall, Julia L Hecht
19. [Comment] Mexico's bold new law on adequate and sustainable nutrition Elisa Pineda, Mauricio Hernández-F, Ana G Ortega-Avila, Alexandra Jones, Juan A Rivera
20. [Comment] Priorities for sickle cell disease global research and implementation Ambroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, Obiageli Nnodu
21. [Comment] Non-communicable diseases: can implementation research change the game for policy and practice? Kumanan Rasanathan, Phyllis Dako-Gyeke, Wanrudee Isaranuwatchai, Yodi Mahendradhata, Morven Roberts, Giulia Loffreda, Sarah Rylance, Bente Mikkelsen
22. [Comment] The role of caregivers in mental health and child development policy and practice Tracey Smythe, Julian Eaton, Adanech Abiebie, Andrea Hernandez Arriaga, Emily Miner
23. [Comment] Challenges in undertaking research in transplantation GC Oniscu, K Rockell, DE Martin
24. [Correspondence] A strong and independent Africa CDC would benefit the world Nelson Aghogho Evaborhene
25. [Department of Error] Department of Error
26. [Correspondence] Tracking COVID-19 responsibly Rania Muhareb, Rita Giacaman
27. [Correspondence] The truth about PHEICs Johan Giesecke, STAG-IH
28. [Review] Current approach of the axilla in patients with early-stage breast cancer Eleftherios P Mamounas, Thorsten Kuehn, Emiel J T Rutgers, Gunter von Minckwitz
29. [Series] The humanitarian system is not just broke, but broken: recommendations for future humanitarian action Paul B Spiegel
30. [Essay] My dying student A Mark Clarfield
31. [Comment] Women, power, and the cancer divide Michelle Bachelet
32. [World Report] 50 years of Medicare Susan Jaffe
更新于 50 分钟前

近期历史最近 100 条记录

2024-09-07 [Correspondence] The need for point-of-care tests for mpox Ranu S Dhillon, Abraar Karan, Devabhaktuni Srikrishna, Jean-Vivien Mombouli
2024-09-06 [Comment] Advancing the economics of health for all Mariana Mazzucato, Tedros Adhanom Ghebreyesus
2024-09-04 [Correspondence] A crisis of safety: female health-care workers in India need reforms Gururaj Arakeri, Vishal Rao, Shankargouda Patil
2024-09-04 [Comment] Addressing global gun violence: a Lancet Commission on Global Gun Violence and Health Adnan A Hyder, Lorena Barberia, Lancet Commission on Global Gun Violence and Health
2024-09-03 [Department of Error] Department of Error
2024-09-03 [Correspondence] Mpox in eastern Democratic Republic of the Congo: challenges and prospects for vaccination Harry César Kayembe Ntumba, Bien-Aimé Makasa Mandja
2024-09-02 [Comment] Optical coherence tomography imaging for complex percutaneous coronary intervention Mamas A Mamas, Gary S Mintz
2024-09-02 [Comment] How feasible is a cage-free solution for de novo coronary artery disease? Margaret B McEntegart, Ajay J Kirtane
2024-09-02 [Articles] Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea Sung-Jin Hong, Seung-Jun Lee, Sang-Hyup Lee, Jong-Young Lee, Deok-Kyu Cho, Jin Won Kim, Sang Min Kim, Seung-Ho Hur, Jung Ho Heo, Ji-Yong Jang, Jin Sin Koh, Hoyoun Won, Jun-Won Lee, Soon Jun Hong, Dong-Kie Kim, Jeong Cheon Choe, Jin Bae Lee, Soo-Joong Kim,
2024-09-02 [Articles] Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial Chao Gao, Xingqiang He, Fan Ouyang, Zhihui Zhang, Guidong Shen, Mingxing Wu, Ping Yang, Likun Ma, Feng Yang, Zheng Ji, Hua Wang, Yanqing Wu, Zhenfei Fang, Hong Jiang, Shangyu Wen, Yi Liu, Fei Li, Jingyu Zhou, Bin Zhu, Yunpeng Liu, Ruining Zhang, Tingting
2024-09-02 [Articles] Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up Holger Thiele, Jacob E Møller, Jose P S Henriques, Margriet Bogerd, Melchior Seyfarth, Daniel Burkhoff, Petr Ostadal, Richard Rokyta, Jan Belohlavek, Steffen Massberg, Marcus Flather, Matthias Hochadel, Steffen Schneider, Steffen Desch, Anne Freund, Hans
2024-09-02 [Comment] Optimal patient and mechanical circulatory support device selection in acute myocardial infarction cardiogenic shock Jacob C Jentzer, Benjamin Hibbert
2024-09-01 [Articles] Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis Pardeep S Jhund, Atefeh Talebi, Alasdair D Henderson, Brian L Claggett, Muthiah Vaduganathan, Akshay S Desai, Carolyn S P Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Scott D Solomon, John J V McMurray
2024-09-01 [Comment] Mineralocorticoid receptor antagonists for every patient with heart failure Frans H Rutten, Amy Groenewegen
2024-08-31 [Articles] De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials Marco Valgimigli, Sung-Jin Hong, Felice Gragnano, Konstantina Chalkou, Anna Franzone, Bruno R da Costa, Usman Baber, Byeong-Keuk Kim, Yangsoo Jang, Shao-Liang Chen, Gregg W Stone, Joo-Yong Hahn, Stephan Windecker, Michael C Gibson, Young Bin Song, Zhen Ge
2024-08-31 [Comment] Is this the conclusive evidence for ticagrelor monotherapy in acute coronary syndromes? Giulio G Stefanini, Angelo Oliva
2024-08-31 [Correspondence] Mpox threat: Pakistan must act now Saad Javed, Nimirta Sahitia, Eesha Yaqoob
2024-08-31 [Correspondence] Enhancing mpox response in Africa with implementation science Abdu A Adamu, Joseph Okeibunor, Reena H Doshi, Charles S Wiysonge
2024-08-30 [Comment] GLP-1 receptor agonists in heart failure: how far to expand use? Camilla Hage
2024-08-30 [Articles] Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials Mikhail N Kosiborod, John Deanfield, Richard Pratley, Barry A Borlaug, Javed Butler, Melanie J Davies, Scott S Emerson, Steven E Kahn, Dalane W Kitzman, Ildiko Lingvay, Kenneth W Mahaffey, Mark C Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, S
2024-08-30 [Correspondence] Far-right riots in the UK: the culmination of years of rhetoric and policies Yamina Boukari, Delan Devakumar
2024-08-30 [Correspondence] 6 months on: South Korean medical students still on leave Dongju Shin, Dong-Jin Shin
2024-08-29 [Seminar] Primary biliary cholangitis Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, John M Vierling
2024-08-29 [Comment] Primary health-care practices for deaf children should include early incorporation of a signed language Wyatte C Hall, Julia L Hecht
2024-08-27 [Correspondence] Bangladesh protests: law enforcement and public health crisis Md Abu Bakkar Siddik
2024-08-24 [Correspondence] The health of migrants at the intersection of mpox and HIV Archibong Edem Bassey
2024-08-23 [Correspondence] Strengthening community resilience: lessons from COVID-19 for mpox prevention Francesco Branda, Giancarlo Ceccarelli, Massimo Ciccozzi, Fabio Scarpa
2024-08-22 [Seminar] X-linked hypophosphataemia Peter Kamenický, Karine Briot, Craig F Munns, Agnès Linglart
2024-08-19 [Comment] The mpox emergency and the role of Gavi Sania Nishtar
2024-08-19 [Editorial] Mpox: the need for a coordinated international response The Lancet
2024-08-17 [Seminar] Obesity in adults Ildiko Lingvay, Ricardo V Cohen, Carel W le Roux, Priya Sumithran
2024-08-17 [Viewpoint] International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches Johan L Dellgren, Govind Persad, Ezekiel J Emanuel
2024-08-17 [Correspondence] Human rights considerations are key when choosing a conference location Shelagh B Coutts, Nikola Sprigg
2024-08-17 [Comment] Transforming humanitarian aid through lived experience Kemish Kenneth Alier
2024-08-15 [Comment] The Glasgow Coma Scale at 50: looking back and forward Geoffrey T Manley, Andrew IR Maas
2024-08-13 [Comment] Nature-based solutions are essential for climate and health action Neil M Vora, Shweta Narayan, Aggrey Aluso, Camila I Donatti, Omnia El Omrani, Lee Hannah, Jemilah Mahmood, Nicaise Ndembi, Mariana M Vale, Elizabeth Willetts
2024-08-09 [Comment] Integrating patient and public involvement and engagement in translational medicine Karen L Shaw, Melanie J Calvert, Persephone Borrow, Evelyn Chakera, Ronjon Chakraverty, Sarah E Hughes, Foram Khatsuria, Francesca A M Kinsella, Christel McMullan, Julie Richardson-Abraham, Vlada Yarosh, Olalekan Lee Aiyegbusi
2024-08-07 [Review] New promises and challenges in the treatment of advanced non-small-cell lung cancer May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares, Federico Cappuzzo, Pasi A Jänne, Solange Peters, Fred R Hirsch
2024-08-02 [Seminar] Acute liver failure Rakhi Maiwall, Anand V Kulkarni, Juan Pablo Arab, Salvatore Piano
2024-08-01 [Comment] Sjögren's disease: a new era for clinical trials? Serena Colafrancesco, Roberta Priori
2024-08-01 [Review] Long COVID: a clinical update Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, Janko Ž Nikolich
2024-08-01 [Articles] Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study Alwin Krämer, Tilmann Bochtler, Chantal Pauli, Kai-Keen Shiu, Natalie Cook, Juliana Janoski de Menezes, Roberto A Pazo-Cid, Ferran Losa, Debbie GJ Robbrecht, Jiří Tomášek, Cagatay Arslan, Mustafa Özgüroğlu, Michael Stahl, Frédéric Bigot, Sun Young Kim, Yo
2024-08-01 [Comment] Molecular guided therapies: a practice-changing step forward in cancer of unknown primary management Elie Rassy, F Anthony Greco, Nicholas Pavlidis
2024-08-01 [Articles] Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study Benjamin A Fisher, Xavier Mariette, Athena Papas, Thomas Grader-Beck, Hendrika Bootsma, Wan-Fai Ng, P L A van Daele, Stephanie Finzel, Ghaith Noaiseh, Sergio Elgueta, Josef Hermann, Sara S McCoy, Esen Akpek, Arthur Bookman, Monika Sopala, Michela Montecch
2024-08-01 [The Lancet Commissions] Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission Gill Livingston, Jonathan Huntley, Kathy Y Liu, Sergi G Costafreda, Geir Selbæk, Suvarna Alladi, David Ames, Sube Banerjee, Alistair Burns, Carol Brayne, Nick C Fox, Cleusa P Ferri, Laura N Gitlin, Robert Howard, Helen C Kales, Mika Kivimäki, Eric B Larso
2024-08-01 [Comment] Pivotal points in the science of dementia risk reduction Miia Kivipelto, Francesca Mangialasche, Kaarin J Anstey
2024-07-26 [Articles] Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study Raed A Joundi, Bo Hu, Sumathy Rangarajan, Darryl P Leong, Shofiqul Islam, Eric E Smith, Erkin Mirrakhimov, Pamela Seron, Khalid F Alhabib, Batyrbek Assembekov, Jephat Chifamba, Rita Yusuf, Rasha Khatib, Camilo Felix, Afzalhussein Yusufali, Noushin Mohamma
2024-07-26 [Comment] A novel treatment approach for atopic dermatitis Patrick M Brunner
2024-07-26 [Viewpoint] Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact James A Berkley, Judd L Walson, Rajiv Bahl, Nigel Rollins
2024-07-26 [Seminar] Chronic lymphocytic leukaemia Nitin Jain, William G Wierda, Susan O'Brien
2024-07-26 [Comment] Global disparities in activity limitations and use of assistive devices Ekaterina Zotcheva, Ellen Melbye Langballe
2024-07-26 [Comment] Mexico's bold new law on adequate and sustainable nutrition Elisa Pineda, Mauricio Hernández-F, Ana G Ortega-Avila, Alexandra Jones, Juan A Rivera
2024-07-25 [Comment] Many crises, one call to action: advancing gender equality in health in response to polycrises Rajat Khosla, Gita Sen, Tedros Adhanom Ghebreyesus, Winnie Byanyima, Sima Bahous, Debora Diniz, Sara Hossain, Natalia Kanem, Ulrika Karlsson, Laura Laski, Dina Mired, Catherine Russell, Tlaleng Mofokeng, Achim Steiner, Volker Türk, Johanna Riha
2024-07-25 [Articles] Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials Jonathan I Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J Legat, Kim A Papp, Linda Stein Gold, Jean-David Bouaziz, Andrew E Pink, José Manuel Carrascosa, Barbara Rewerska, Jacek C Szepietowski, Dorota Krasowska, Blanka Havlíčková, Moni
2024-07-25 [Comment] Realigning the physical activity research agenda for population health, equity, and wellbeing Ding Ding, Sebastien Chastin, Deborah Salvo, Tracy Nau, Klaus Gebel, Miguel Adriano Sanchez-Lastra, Mengyun Luo, Inacio Crochemore-Silva, Ulf Ekelund, Adrian Bauman
2024-07-24 [Perspectives] Mandy Cohen: public health advocate and Director of the US CDC Susan Jaffe
2024-07-23 [Perspectives] Rochelle Burgess: disrupting the status quo in global mental health Rachael Davies
2024-07-19 [Seminar] Renal cell carcinoma Matthew Young, Francesca Jackson-Spence, Luis Beltran, Elizabeth Day, Christina Suarez, Axel Bex, Thomas Powles, Bernadett Szabados
2024-07-19 [Articles] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials Robert Bissonnette, Richard B Warren, Andreas Pinter, Tove Agner, Melinda Gooderham, Marie L A Schuttelaar, Marie-Noëlle Crépy, Luca Stingeni, Esther Serra-Baldrich, Keith Baranowski, Sofie Korn, Merle Kurvits, Ursula Plohberger, Natacha Strange Vest, Sib
2024-07-19 [Comment] Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczema Yael Renert-Yuval, Emma Guttman-Yassky
2024-07-16 [Perspectives] Kathleen Maletic Neuzil: new Fogarty International Center leader Udani Samarasekera
2024-07-13 [Comment] Unlocking the power of NHS research: a priority for the new UK Government Andrew Morris
2024-07-12 [Therapeutics] Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment Torsten Zuberbier, Luis Felipe Ensina, Ana Giménez-Arnau, Clive Grattan, Emek Kocatürk, Kanokvalai Kulthanan, Pavel Kolkhir, Marcus Maurer
2024-07-12 [Comment] Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions Anthony Muchai Manyara, Oriana Ciani, Rod S Taylor, SPIRIT-Surrogate and CONSORT-Surrogate Project team and Consensus Group
2024-07-11 [Comment] Priorities for sickle cell disease global research and implementation Ambroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, Obiageli Nnodu
2024-07-10 [Department of Error] Department of Error
2024-07-10 [Comment] The UK Government's mandate for change must prioritise transformation of the public's health Kevin Fenton, Greg Fell, William Roberts, Margaret Rae
2024-07-10 [Comment] CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma Maria-Luisa Schubert, Peter Dreger
2024-07-10 [Articles] CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study Matthew J Frank, John H Baird, Anne Marijn Kramer, Hrishikesh K Srinagesh, Shabnum Patel, Annie Kathleen Brown, Jean S Oak, Sheren F Younes, Yasodha Natkunam, Mark P Hamilton, Yi-Jiun Su, Neha Agarwal, Harshini Chinnasamy, Emily Egeler, Sharon Mavroukakis
2024-07-09 [Comment] Self-guided digital acceptance and commitment therapy as a treatment option for fibromyalgia Guilherme Torres Vilarino
2024-07-09 [Articles] Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial R Michael Gendreau, Lance M McCracken, David A Williams, Juan V Luciano, Yifei Dai, Nicolette Vega, Zunera Ghalib, Kristen Guthrie, Allison C Kraus, Michael J Rosenbluth, Ben Vaughn, Jennifer M Zomnir, Dana Reddy, Andrea L Chadwick, Daniel J Clauw, Lesley
2024-07-06 [Correspondence] Counting the dead in Gaza: difficult but essential Rasha Khatib, Martin McKee, Salim Yusuf
2024-07-05 [Comment] Physician associates in the UK and the role of the doctor Jessamy Bagenal
2024-07-04 [Articles] Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zij
2024-07-04 [Comment] The CONCORD–Lancet Global Commission on Cancer Claudia Allemani, Gulnar Azevedo e Silva, Prashant Mathur, Michel P Coleman
2024-07-02 [Comment] Non-communicable diseases: can implementation research change the game for policy and practice? Kumanan Rasanathan, Phyllis Dako-Gyeke, Wanrudee Isaranuwatchai, Yodi Mahendradhata, Morven Roberts, Giulia Loffreda, Sarah Rylance, Bente Mikkelsen
2024-06-29 [Correspondence] Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis I Sermet-Gaudelus, Sihem Benaboud, Stéphanie Bui, Tiphaine Bihouée, Sophie Gautier, MODUL-CF study group
2024-06-28 [Articles] Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial Jiamin Liu, Yan Li, Jinzhuo Ge, Xiaofang Yan, Haibo Zhang, Xin Zheng, Jiapeng Lu, Xi Li, Yan Gao, Lubi Lei, Jing Liu, Jing Li, ESPRIT Collaborative Group
2024-06-28 [Comment] Mounting evidence in favour of the lower, the better blood pressure paradigm Kazem Rahimi
2024-06-28 [Comment] Delivering the promise of improved health for women and girls in England Jane Elizabeth Hirst, Alice Witt, Edward Mullins, Kate Womersley, Dorcus Muchiri, Robyn Norton
2024-06-27 [Seminar] Neonatal bacterial sepsis Tobias Strunk, Eleanor J Molloy, Archita Mishra, Zulfiqar A Bhutta
2024-06-27 [Articles] Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam: an open-label randomised controlled trial Vu N A Ho, Toan D Pham, Nam T Nguyen, Rui Wang, Robert J Norman, Ben W Mol, Tuong M Ho, Lan N Vuong
2024-06-27 [Correspondence] Implications of suboptimal measles immunity in UK health-care workers Antonia Ho, Oliver Galgut, Sian Faustini, Nicholas Peters, Adrian Shields, Paul Klenerman, Susan Hopkins, Victoria Hall, Susanna Dunachie, Alex Richter
2024-06-27 [Correspondence] Floods in south Brazil: more than an environmental crisis Guilherme Pinheiro Machado
2024-06-27 [Comment] Efficiency and drawbacks of frozen embryo transfers from artificial versus natural cycles Anja Pinborg, Kristine Løssl
2024-06-27 [Correspondence] Diabetes management amidst floods in Brazil Lucas Strassburger Matzenbacher, Janine Alessi, Gabriela Heiden Telo
2024-06-26 [Correspondence] Oral diseases in Palestine David T Zhu, Kate Zinszer, Samer Abuzerr
2024-06-21 [Seminar] Colorectal cancer Cathy Eng, Takayuki Yoshino, Erika Ruíz-García, Nermeen Mostafa, Christopher G Cann, Brittany O'Brian, Amala Benny, Rodrigo O Perez, Chiara Cremolini
2024-06-21 [Series] Pathophysiology from preconception, during pregnancy, and beyond Marie-France Hivert, Helena Backman, Katrien Benhalima, Patrick Catalano, Gernot Desoye, Jincy Immanuel, Christopher J D McKinlay, Claire L Meek, Christopher J Nolan, Uma Ram, Arianne Sweeting, David Simmons, Alicia Jawerbaum
2024-06-21 [Series] Epidemiology and management of gestational diabetes Arianne Sweeting, Wesley Hannah, Helena Backman, Patrick Catalano, Maisa Feghali, Willliam H Herman, Marie-France Hivert, Jincy Immanuel, Claire Meek, Maria Lucia Oppermann, Christopher J Nolan, Uma Ram, Maria Inês Schmidt, David Simmons, Tawanda Chivese,
2024-06-21 [Series] Call to action for a life course approach David Simmons, Yashdeep Gupta, Teri L Hernandez, Naomi Levitt, Mireille van Poppel, Xilin Yang, Christina Zarowsky, Helena Backman, Maisa Feghali, Karoline Kragelund Nielsen
2024-06-21 [Editorial] Non-communicable diseases in reproductive care The Lancet
2024-06-20 [Articles] Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial Natasha C Pocovi, Chung-Wei Christine Lin, Simon D French, Petra L Graham, Johanna M van Dongen, Jane Latimer, Dafna Merom, Anne Tiedemann, Christopher G Maher, Ornella Clavisi, Shuk Yin Kate Tong, Mark J Hancock
2024-06-20 [Comment] Physical activity to prevent recurrences of low back pain Diarmuid Denneny, Jackie Walumbe
2024-06-18 [Comment] Political courage needed to prevent the next pandemic Helen Clark, Mauricio Cárdenas, Mark Dybul, Michel Kazatchkine, Joanne Liu, Henry E Mark, Rosemary McCarney, Christine McNab, David Miliband, Anders Nordström, Thoraya Ahmed Obaid, Raj Panjabi, Elizabeth Radin, George Werner, Ellen Johnson Sirleaf
2024-06-18 [Comment] The updated International Health Regulations: good news for global health equity Ashley Bloomfield, Abdullah Assiri
2024-06-15 [Seminar] Peptic ulcer disease Majid A Almadi, Yidan Lu, Ali A Alali, Alan N Barkun
2024-06-14 [Articles] Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial Amber Meulenbeld, Steven Ramondt, Maike G Sweegers, Franke A Quee, Femmeke J Prinsze, Emiel O Hoogendijk, Dorine W Swinkels, Katja van den Hurk
2024-06-14 [Comment] A programme for greater health equity for the next UK Government Michael Marmot, Jessica Allen
2024-06-14 [Department of Error] Department of Error

匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选